✦ LIBER ✦

Conversion to mycophenolate mofetil (MMF) instead of cyclosporine a (CYA) in liver transplant (LT) recipients with renal function impairment. A pilot study

✍ Scribed by J.I. Herrero; J. Quiroga; B. Sangro; M. Girala; N. Gómez; A. Beltrán; F. Pardo; J.A. Cienfuegos; J. Prieto

Book ID: 118568575
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 159 KB
Volume: 28
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(98)80808-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A pilot study of cyclosporine withdrawal

A pilot study of cyclosporine withdrawal in stable renal transplant recipients after azathioprine–mycophenolate mofetil conversion

✍ E Thervet; E Morelon; D Ducloux; L Bererhi; L.H Noël; A Janin; J Bedrossian; S P 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Improvement of Renal Function After Conv

Improvement of Renal Function After Conversion to Mycophenolate Mofetil Combined With Low-Level Calcineurin Inhibitor in Liver Transplant Recipients With Chronic Renal Dysfunction

✍ C. Ponton; L. Vizcaíno; S. Tomé; E. Otero; E. Molina; J.F. Castroagudín; A. Lópe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 195 KB

Conversion From Calcineurin Inhibitor to

Conversion From Calcineurin Inhibitor to Either Mycophenolate Mofetil or Sirolimus Improves Renal Function in Liver Transplant Recipients With Chronic Kidney Disease: Results of a Prospective Randomized Trial

✍ G. Herlenius; M. Felldin; G. Nordén; M. Olausson; L. Bäckman; B. Gustafsson; S. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 764 KB

A randomized controlled trial of late co

A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function

✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB 👁 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin